Centogene B V Stock Return On Equity
| CNTG Stock | USD 0.10 0.02 16.67% |
Centogene B V fundamentals help investors to digest information that contributes to Centogene's financial success or failures. It also enables traders to predict the movement of Centogene Stock. The fundamental analysis module provides a way to measure Centogene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Centogene stock.
| Last Reported | Projected for Next Year | ||
| Return On Equity | 1.38 | 1.44 |
Centogene | Return On Equity |
Centogene B V Company Return On Equity Analysis
Centogene's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Centogene Return On Equity | -13.75 |
Most of Centogene's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Centogene B V is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Centogene Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Centogene is extremely important. It helps to project a fair market value of Centogene Stock properly, considering its historical fundamentals such as Return On Equity. Since Centogene's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Centogene's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Centogene's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Centogene Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Centogene B V has a Return On Equity of -13.7533. This is 42.62% lower than that of the Health Care Providers & Services sector and 105.89% higher than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Centogene Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Centogene's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Centogene could also be used in its relative valuation, which is a method of valuing Centogene by comparing valuation metrics of similar companies.Centogene is currently under evaluation in return on equity category among its peers.
Centogene Current Valuation Drivers
We derive many important indicators used in calculating different scores of Centogene from analyzing Centogene's financial statements. These drivers represent accounts that assess Centogene's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Centogene's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 147.3M | 184.4M | 103.2M | 23.3M | 30.6M | 29.0M | |
| Enterprise Value | 137.7M | 165.4M | 112.6M | 51.4M | 91.9M | 173.6M |
Centogene Fundamentals
| Return On Equity | -13.75 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (0.73) % | ||||
| Operating Margin | (0.63) % | ||||
| Current Valuation | 69.09 M | ||||
| Shares Outstanding | 29 M | ||||
| Shares Owned By Insiders | 4.56 % | ||||
| Shares Owned By Institutions | 66.89 % | ||||
| Number Of Shares Shorted | 81.71 K | ||||
| Price To Earning | (6.69) X | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 0.19 X | ||||
| Revenue | 47.54 M | ||||
| Gross Profit | 35.9 M | ||||
| EBITDA | (30.87 M) | ||||
| Net Income | (34.8 M) | ||||
| Cash And Equivalents | 42.67 M | ||||
| Cash Per Share | 1.58 X | ||||
| Total Debt | 80.41 M | ||||
| Debt To Equity | 1.31 % | ||||
| Current Ratio | 2.48 X | ||||
| Book Value Per Share | (0.87) X | ||||
| Cash Flow From Operations | (36.96 M) | ||||
| Short Ratio | 0.82 X | ||||
| Earnings Per Share | (1.39) X | ||||
| Target Price | 1.52 | ||||
| Number Of Employees | 384 | ||||
| Beta | -0.67 | ||||
| Market Capitalization | 9.43 M | ||||
| Total Asset | 77.22 M | ||||
| Retained Earnings | (177.36 M) | ||||
| Working Capital | 653 K | ||||
| Current Asset | 57.14 M | ||||
| Current Liabilities | 30.14 M | ||||
| Net Asset | 77.22 M |
About Centogene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Centogene B V's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Centogene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Centogene B V based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Centogene B V is a strong investment it is important to analyze Centogene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Centogene's future performance. For an informed investment choice regarding Centogene Stock, refer to the following important reports:Check out Centogene Piotroski F Score and Centogene Altman Z Score analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centogene. If investors know Centogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 1.723 | Quarterly Revenue Growth (0.08) | Return On Assets (0.27) | Return On Equity (13.75) |
The market value of Centogene B V is measured differently than its book value, which is the value of Centogene that is recorded on the company's balance sheet. Investors also form their own opinion of Centogene's value that differs from its market value or its book value, called intrinsic value, which is Centogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centogene's market value can be influenced by many factors that don't directly affect Centogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Centogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.